Trials / Completed
CompletedNCT04419636
Binding of Lu AG06466 in the Brain in Healthy Men
Interventional, Open-label, Position Emission Tomography (PET) Study Investigating MAGL Occupancy After Single and Multiple Oral Doses of Lu AG06466 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A study to learn how Lu AG06466 and one of its break down products binds in the brain after single and repeated dosing
Detailed description
The study will be conducted in two Parts. Part A: cross over, fed/fasted determined by randomized sequence Part B: sequential group PET scans will be used to quantify MAGL occupancy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lu AG06466 | capsules, orally |
Timeline
- Start date
- 2020-05-29
- Primary completion
- 2021-02-09
- Completion
- 2021-02-16
- First posted
- 2020-06-05
- Last updated
- 2021-02-24
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04419636. Inclusion in this directory is not an endorsement.